The global prevalence of OA attributed to high BMI has steadily increased over the past 3 decades, particularly among women and in high-SDI regions.

Intravenous belimumab plus SOC vs placebo plus SOC was not linked to an increased risk for infection among patients with SLE.

Health insurance companies have pledged to improve prior authorization with 6 key reforms, according to the HHS.